Potential Glioblastoma Therapy with Cationic Cyclodextrin Polymers as Drug Delivery Excipients
Glioblastoma (GB) is the most common and aggressive malignant brain tumor, with a median survival of only 12–15 months despite
A forum for researchers, students and applicants in the field of cyclodextrin technology
Glioblastoma (GB) is the most common and aggressive malignant brain tumor, with a median survival of only 12–15 months despite
Addressing disorders related to the central nervous system (CNS) remains a complex challenge because of the presence of the blood-brain